The link between smoking and impotence: two decades of evidence.

BACKGROUND Anti-tobacco advertisements now feature the risk of impotence as a reason to avoid or cease tobacco use. The scientific evidence, however, is mixed. To shed light on the controversy, we compiled 2 decades of published data on the link between smoking and impotence. METHODS We searched MEDLINE from 1980 to the present for studies that reported smoking prevalence among impotent male subjects. For each study we recorded the age of subjects, their state of residence, the percentage that were current smokers, and the time period over which study data were collected. For comparison purposes, we estimated age-, state-, and year-specific smoking rates in the general male population using the Behavioral Risk Factors Surveillance System. We performed a meta-analysis using a random effects model. RESULTS Among the 1008 journal articles examined, we identified 19 studies that reported the smoking habits of 3819 impotent men. Of these 19 studies, 16 indicated a smoking prevalence exceeding that of the general population. The 6 largest studies all revealed a higher prevalence of smoking among impotent men. Meta-analysis reveals that 40% of impotent men were current smokers compared with 28% of men in the general population. CONCLUSIONSBased on almost 2 decades of evidence, tobacco use is an important risk factor for impotence. Anti-tobacco advertisements featuring impotence as a reason to avoid or cease tobacco use are well grounded in scientific fact.

[1]  S. S. Davis,et al.  Biweekly intracavernous administration of papaverine for erectile dysfunction. , 1989, The Western journal of medicine.

[2]  D. L. McKay,et al.  Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC). Multi-institutional study. , 1993, Urology.

[3]  M. Bettmann,et al.  Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. , 1991, The Journal of urology.

[4]  W. Butler,et al.  Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. , 1999, Urology.

[5]  F. B. Scott,et al.  Evaluation of erectile impotence. , 1988, Urology.

[6]  F. Parazzini,et al.  The epidemiology of erectile dysfunction and its risk factors. , 1998, International journal of andrology.

[7]  L. Horowitz,et al.  Noninvasive penile arterial evaluation in 120 males with erectile dysfunction. , 1983, Urology.

[8]  G. Badlani,et al.  Utility of Rigiscan and papaverine in diagnosis of erectile impotence. , 1988, Urology.

[9]  R. Bonnie,et al.  Growing up Tobacco Free: Preventing Nicotine Addiction in Children and Youths , 1994 .

[10]  L. Lantinga,et al.  Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. , 1991, The Journal of urology.

[11]  C. Begg,et al.  Publication bias : a problem in interpreting medical data , 1988 .

[12]  R. Shabsigh,et al.  Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography. , 1989, The Journal of urology.

[13]  L. Kuritzky,et al.  Evaluation and treatment of impotence: a pragmatic approach addressing organic and psychogenic components. , 1988, Family practice research journal.

[14]  M. Hirshkowitz,et al.  Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. , 1992, Urology.

[15]  A. Melman,et al.  The epidemiology of erectile dysfunction. , 1995, The Urologic clinics of North America.

[16]  R. Kirby Fortnightly Review: Impotence: diagnosis and management of male erectile dysfunction , 1994 .

[17]  R. Simes Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Merenich,et al.  Trial of Pentoxifylline for Diabetic Impotence , 1995, Diabetes Care.

[19]  A. Melman,et al.  The success of microsurgical penile revascularization in treating arteriogenic impotence. , 1993, International journal of impotence research.

[20]  R. Schiavi,et al.  Sexuality and aging. , 1995, The Urologic clinics of North America.

[21]  S. S. Davis,et al.  Impotence and Aging: Clinical and Hormonal Factors , 1988, Journal of the American Geriatrics Society.

[22]  K. Hanash Comparative results of goal oriented therapy for erectile dysfunction. , 1997, The Journal of urology.

[23]  W. Steers,et al.  Oral trazodone as empirical therapy for erectile dysfunction: a retrospective review. , 1995, Urology.

[24]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[25]  R. Depalma,et al.  Noninvasive assessment of impotence. , 1990, The Surgical clinics of North America.

[26]  T. Lin,et al.  Chronic testosterone cypionate therapy in men with secondary impotence. , 1986, Fertility and sterility.

[27]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[28]  D. Mannino,et al.  Cigarette smoking: an independent risk factor for impotence? , 1994, American journal of epidemiology.

[29]  H A Feldman,et al.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.